

Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target

Lead Product(s) : Sodium Lactate
Therapeutic Area : Hepatology (Liver, Pancreatic, Gall Bladder)
Study Phase : Phase IV
Sponsor : Instituto de Salud Carlos III | Universidad Miguel Hernandez de Elche | Hospital del Mar | Hospital Clinico Universitario de Santiago | Hospital Clínico Universitario de Valencia | Hospital Costa del Sol | Corporacion Parc Tauli | Hospital Clínico Univers
Deal Size : Inapplicable
Deal Type : Inapplicable
Normal Saline Versus Lactated Ringer's Solution for Acute Pancreatitis Resuscitation
Details : Sodium Lactate is a Other Small Molecule drug candidate, which is currently being evaluated in phase IV clinical studies for the treatment of Pancreatitis.
Product Name : Undisclosed
Product Type : Miscellaneous
Upfront Cash : Inapplicable
March 23, 2023
Lead Product(s) : Sodium Lactate
Therapeutic Area : Hepatology (Liver, Pancreatic, Gall Bladder)
Highest Development Status : Phase IV
Sponsor : Instituto de Salud Carlos III | Universidad Miguel Hernandez de Elche | Hospital del Mar | Hospital Clinico Universitario de Santiago | Hospital Clínico Universitario de Valencia | Hospital Costa del Sol | Corporacion Parc Tauli | Hospital Clínico Univers
Deal Size : Inapplicable
Deal Type : Inapplicable

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Lead Product(s) : Sodium Lactate
Therapeutic Area : Trauma (Emergency, Injury, Surgery)
Study Phase : Phase IV
Sponsor : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable
Efficacy and Safety of Rheosorbilact® Solution for Infusion, in a Complex Therapy of Burns
Details : Sodium Lactate is a Other Small Molecule drug candidate, which is currently being evaluated in phase IV clinical studies for the treatment of Burns.
Product Name : Undisclosed
Product Type : Miscellaneous
Upfront Cash : Inapplicable
November 05, 2019
Lead Product(s) : Sodium Lactate
Therapeutic Area : Trauma (Emergency, Injury, Surgery)
Highest Development Status : Phase IV
Sponsor : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable

Lead Product(s) : Sodium Lactate
Therapeutic Area : Trauma (Emergency, Injury, Surgery)
Study Phase : Phase III
Sponsor : Boston Children's Hospital | Children's Healthcare of Atlanta | Children's Hospital Colorado | Children's Hospital Los Angeles | The University of Pittsburgh School of Medicine | Morgan Stanley Children’s Hospital | Children's Hospital and Health System F
Deal Size : Inapplicable
Deal Type : Inapplicable
Pragmatic Pediatric Trial of Balanced Versus Normal Saline Fluid in Sepsis
Details : Sodium Lactate is a Other Small Molecule drug candidate, which is currently being evaluated in phase III clinical studies for the treatment of Shock.
Product Name : Undisclosed
Product Type : Miscellaneous
Upfront Cash : Inapplicable
September 25, 2019
Lead Product(s) : Sodium Lactate
Therapeutic Area : Trauma (Emergency, Injury, Surgery)
Highest Development Status : Phase III
Sponsor : Boston Children's Hospital | Children's Healthcare of Atlanta | Children's Hospital Colorado | Children's Hospital Los Angeles | The University of Pittsburgh School of Medicine | Morgan Stanley Children’s Hospital | Children's Hospital and Health System F
Deal Size : Inapplicable
Deal Type : Inapplicable

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Lead Product(s) : Sodium Lactate
Therapeutic Area : Infections and Infectious Diseases
Study Phase : Phase IV
Sponsor : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable
Efficacy and Safety of Rheosorbilact® Solution for Infusion, in a Complex Therapy of Pneumonia
Details : Sodium Lactate is a Other Small Molecule drug candidate, which is currently being evaluated in phase IV clinical studies for the treatment of Pneumonia.
Product Name : Undisclosed
Product Type : Miscellaneous
Upfront Cash : Inapplicable
January 31, 2019
Lead Product(s) : Sodium Lactate
Therapeutic Area : Infections and Infectious Diseases
Highest Development Status : Phase IV
Sponsor : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Lead Product(s) : Sodium Lactate
Therapeutic Area : Gastroenterology
Study Phase : Phase IV
Sponsor : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable
Efficacy and Safety of Rheosorbilact® Solution for Infusion, in a Complex Therapy of Peritonitis
Details : Sodium Lactate is a Other Small Molecule drug candidate, which is currently being evaluated in phase IV clinical studies for the treatment of Peritonitis.
Product Name : Undisclosed
Product Type : Miscellaneous
Upfront Cash : Inapplicable
December 11, 2018
Lead Product(s) : Sodium Lactate
Therapeutic Area : Gastroenterology
Highest Development Status : Phase IV
Sponsor : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Lead Product(s) : Sodium Lactate
Therapeutic Area : Infections and Infectious Diseases
Study Phase : Phase IV
Sponsor : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable
Efficacy and Safety of Rheosorbilact® Solution for Infusion, in a Complex Therapy of Sepsis.
Details : Sodium Lactate is a Other Small Molecule drug candidate, which is currently being evaluated in phase IV clinical studies for the treatment of Sepsis.
Product Name : Undisclosed
Product Type : Miscellaneous
Upfront Cash : Inapplicable
December 04, 2018
Lead Product(s) : Sodium Lactate
Therapeutic Area : Infections and Infectious Diseases
Highest Development Status : Phase IV
Sponsor : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable

Lead Product(s) : Sodium Lactate
Therapeutic Area : Cardiology/Vascular Diseases
Study Phase : Phase II
Sponsor : Innogene Kalbiotech
Deal Size : Inapplicable
Deal Type : Inapplicable
0.5M Na Lactate Solution in Acute Heart Failure (AHF)
Details : Sodium Lactate is a Other Small Molecule drug candidate, which is currently being evaluated in phase II clinical studies for the treatment of Heart Failure.
Product Name : Undisclosed
Product Type : Miscellaneous
Upfront Cash : Inapplicable
November 11, 2013
Lead Product(s) : Sodium Lactate
Therapeutic Area : Cardiology/Vascular Diseases
Highest Development Status : Phase II
Sponsor : Innogene Kalbiotech
Deal Size : Inapplicable
Deal Type : Inapplicable
